ISOREBAUDIOSIDE A(P)
|
- $250 - $950
- Product name: ISOREBAUDIOSIDE A(P)
- CAS: 1058600-85-3
- MF: C44H70O23
- MW: 967.02
- EINECS:
- MDL Number:
- Synonyms:ISOREBAUDIOSIDE A(P);(4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-15-en-18-oic acid beta-D-glucopyranosyl ester;DAQ 3;Isorebaudioside A;Kaur-15-en-18-oic acid, 13-[(O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranosyl)oxy]-, β-D-glucopyranosyl ester, (4α)-
4 prices
Selected condition：
Brand
- Biosynth Carbosynth
Package
- 1mg
- 2mg
- 5mg
- 10mg
- ManufacturerBiosynth Carbosynth
- Product numberOI44879
- Product descriptionIsorebaudioside A
- Packaging1mg
- Price$250
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberOI44879
- Product descriptionIsorebaudioside A
- Packaging2mg
- Price$370
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberOI44879
- Product descriptionIsorebaudioside A
- Packaging5mg
- Price$625
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberOI44879
- Product descriptionIsorebaudioside A
- Packaging10mg
- Price$950
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Biosynth Carbosynth | OI44879 | Isorebaudioside A | 1mg | $250 | 2021-12-16 | Buy |
| Biosynth Carbosynth | OI44879 | Isorebaudioside A | 2mg | $370 | 2021-12-16 | Buy |
| Biosynth Carbosynth | OI44879 | Isorebaudioside A | 5mg | $625 | 2021-12-16 | Buy |
| Biosynth Carbosynth | OI44879 | Isorebaudioside A | 10mg | $950 | 2021-12-16 | Buy |
Properties
Melting point :177-181 °C
Boiling point :1102.3±65.0 °C(Predicted)
Density :1.59±0.1 g/cm3(Predicted)
pka :12.51±0.70(Predicted)
Boiling point :1102.3±65.0 °C(Predicted)
Density :1.59±0.1 g/cm3(Predicted)
pka :12.51±0.70(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|